Evidence map›Paper›PMID 24317252›Full record

ArticleNature methods2014

Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification.

Housheng Hansen He, Clifford A Meyer, Sheng'en Shawn Hu, Mei-Wei Chen, Chongzhi Zang, Yin Liu, Prakash K Rao, Teng Fei, Han Xu, Henry Long and 2 more

Abstract read
In one paragraph

Article in Nature methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. XL-DNase-Seq: Footprinting Analysis of Dynamic Transcription Factors.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  19. Review
  20. Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Housheng Hansen He *Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Clifford A Meyer *Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Sheng'en Shawn Hu *Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Mei-Wei ChenCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Chongzhi ZangDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Yin LiuCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Prakash K RaoCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Teng FeiDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Han XuDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Henry LongCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
X Shirley LiuDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Myles BrownDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

Funding

Tumor and Circulating Markers as Links Between Obesity and Lethal Prostate CanceP50CA090381 · NCI · DANA-FARBER CANCER INSTITUTE · PI REGAN, MEREDITH M · 2002 to 2017
$36.2M
EDAC: ENCODE Data Analysis CenterU41HG007000 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WENG, ZHIPING · 2012 to 2016
$9.8M
Comprehensive Analysis of Estrogen Receptor Genomic ActionR01DK074967 · NIDDK · DANA-FARBER CANCER INST · PI BROWN, MYLES A · 2007 to 2011
$2.9M
Inferring Mammalian Transcriptional Regulatory Networks from EpigenomicsR01GM099409 · NIGMS · DANA-FARBER CANCER INST · PI LIU, XIAOLE SHIRLEY · 2011 to 2014
$1.4M
Epigenetic Regulators in Cancer Development and ProgressionK99CA172948 · NCI · DANA-FARBER CANCER INST · PI HE, HOUSHENG · 2013 to 2013
$63k
NCI NIH HHS 1K99CA172948-01NCI NIH HHS 2P50 CA090381-06NCI NIH HHS K99 CA172948NCI NIH HHS P50 CA090381NHGRI NIH HHS 1U41 HG007000NHGRI NIH HHS U41 HG007000NIDDK NIH HHS 2R01 DK074967-06NIDDK NIH HHS R01 DK074967NIGMS NIH HHS 1R01 GM099409NIGMS NIH HHS R01 GM099409
6 · The paper itself

Abstract

Sequencing of DNase I hypersensitive sites (DNase-seq) is a powerful technique for identifying cis-regulatory elements across the genome. We studied the key experimental parameters to optimize performance of DNase-seq. Sequencing short fragments of 50-100 base pairs (bp) that accumulate in long internucleosome linker regions was more efficient for identifying transcription factor binding sites compared to sequencing longer fragments. We also assessed the potential of DNase-seq to predict transcription factor occupancy via generation of nucleotide-resolution transcription factor footprints. In modeling the sequence-specific DNase I cutting bias, we found a strong effect that varied over more than two orders of magnitude. This indicates that the nucleotide-resolution cleavage patterns at many transcription factor binding sites are derived from intrinsic DNase I cleavage bias rather than from specific protein-DNA interactions. In contrast, quantitative comparison of DNase I hypersensitivity between states can predict transcription factor occupancy associated with particular biological perturbations.

Indexed as

Gene Regulatory NetworksAmino Acid MotifsBinding SitesCell Line, TumorChromatinDeoxyribonuclease IFemaleGene Expression RegulationHumansK562 CellsMaleMCF-7 CellsNucleosomesNucleotidesReceptors, AndrogenSequence Analysis, DNAChromatinDeoxyribonuclease INucleosomesNucleotidesReceptors, AndrogenTP53 protein, humanTranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID24317252
PMCPMC4018771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.